Format

Send to

Choose Destination
Mol Med Today. 1998 Apr;4(4):166-73.

Vaccines against Chlamydia: approaches and progress.

Author information

1
Antigen Presentation Research Group, Imperial College School of Medicine at Northwick Park Hospital, Harrow, Middlesex, UK. a.stagg@ic.ac.uk

Abstract

Infections of the eye and genital tract with the bacterium Chlamydia trachomatis are a major cause of morbidity worldwide and are costly to treat. Development of a vaccine capable of protecting against infection or severe disease presents special challenges but would be the most effective long-term option for control of chlamydial disease. Progress has been made in understanding protective and pathological immune mechanisms in these infections, and a number of potential vaccine candidates have been developed.

PMID:
9572058
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center